Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FloraBaby is a multi-strain probiotic dietary supplement formulated specifically for infants and young children. It contains five strains of beneficial bacteria commonly found in the intestinal tract of children, including Bifidobacterium breve, Lactobacillus rhamnosus, Bifidobacterium bifidum, Bifidobacterium infantis (Bifidobacterium longum subsp. infantis), and Bifidobacterium longum. The product is designed to support gastrointestinal health and help establish or restore healthy gut flora in newborns and young children. It is available as a flavorless powder that can be mixed into cool or warm liquids or soft foods for easy administration[3][4][5][6]. Clinical use includes prevention of severe necrotizing enterocolitis (NEC) in preterm infants[2]. The product does not contain gluten or GMOs but may contain traces of milk and soy from fermentation ingredients[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on FloraBaby.